Untreated Donor-Specific HLA Antibodies Are Associated With Graft Failure and Poor Survival After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Pediatric Patients With Nonmalignant Disorders-Reference-Cited by-同舟云学术

Untreated Donor-Specific HLA Antibodies Are Associated With Graft Failure and Poor Survival After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Pediatric Patients With Nonmalignant Disorders

Published:2022-10 Issue:10 Volume:28 Page:698.e1-698.e11
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Lima Alberto Cardoso Martins^ORCID,Bonfim Carmem,Getz Joselito^ORCID,do Amaral Geovana Borsato,Petterle Ricardo Rasmussen^ORCID,Loth Gisele,Nabhan Samir Kanaan,de Marco Renato^ORCID,Gerbase-DeLima Maria^ORCID,Pereira Noemi Farah,Pasquini Ricardo

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference53 articles.

1. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor;Bashey;Bone Marrow Transplant,2014

2. Haploidentical bone marrow transplantation with post-transplant cyclophosphamide for children and adolescents with Fanconi anemia;Bonfim;Biol Blood Marrow Transplant,2017

3. Impact of CD34 Cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia;Arcuri;Biol Blood Marrow Transplant,2020

4. Outcomes after haploidentical stem cell transplantation with post-transplantation cyclophosphamide in patients with primary immunodeficiency diseases;Fernandes;Biol Blood Marrow Transplant,2020

5. Haploidentical bone marrow transplantation with post-transplantation cyclophosphamide plus thiotepa improves donor engraftment in patients with sickle cell anemia: results of an international learning collaborative;de la Fuente;Biol Blood Marrow Transplant,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies;Transplantation and Cellular Therapy;2024-09

2. Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT;Blood;2024-07-18

3. Donor selection in allogeneic stem cell transplantation;Current Opinion in Hematology;2024-07-16

4. Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know;Oncology and Therapy;2024-06-15

5. Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2023-08